Biolegend reagents

Ended Purchase Order Awarded Last action

Contract number
75N90023P00468
Awardee
Awarding agency
Obligated
$29,645

Award facts

Contract value 100% obligated
$29,645.10 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,645.10 firm fixed price purchase order to Biolegend, Inc. for BIOLEGEND REAGENTS. Biolegend, Inc. is a subsidiary of Revvity Inc. Medical Imaging, LLC. The place of performance will be Biolegend's facilities located in San Diego, California. The period of performance is from June 27, 2023 through September 30, 2023. No additional details were provided regarding subcontractors or the NIH Clinical Center's programs. The award does not appear to be associated with a multiple award contract vehicle.

Quick answers

Who was awarded contract 75N90023P00468?

75N90023P00468 was awarded to Biolegend, Inc. by NIH Clinical Center (National Institutes of Health) on June 27, 2023.

How much is contract 75N90023P00468 worth?

The government has obligated $29,645 on 75N90023P00468.

Was contract 75N90023P00468 competed?

The extent of competition for 75N90023P00468 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award